Sherif is a life scientist with over 25 years of experience in the higher education sector, focusing on research, innovation, translation, and commercialisation. He is trained as a pharmacist, followed by a PhD in genomic medicine from the University of Sussex, then postdoctoral training at St Jude Hospital in the US. Working with the Nobel Laureate Zewail at Caltech, he established and directed one of the first medical genomics research centres in the MENA region. In 2018, he co-founded the Healthy Lifespan Institute at the University of Sheffield. Sherif moved to the University of Bradford in 2020 as the Director of the Institute of Cancer Therapeutics, then Associate Dean of Research, and then took up the Pro-Vice Chancellor role in 2024. Sherif is responsible for the leadership and management of the University of Bradford Research and Innovation ecosystem. He has significant experience working in higher education here in the UK and in the MENA region, championing the quality of research and innovation, student experience, and engagement with the government and private sectors. Sherif's core technical background is in genomic medicine with a broader economic focus through working with senior executives and stakeholders. Sherif is a Wellcome Trust Investigator, a Fellow of the Lister Institute of Preventative Medicine, and sits on UKRI and Wellcome Trust funding panels. Sherif's lab work in biology and medicine is published in journals such as Nature, Cell, and Science. Sherif is an elected Fellow of the Royal Society of Biology and the Royal Society of Chemistry. His work has been recognised by AstraZeneca (UK), Caltech (USA), Awards of Excellence in Medical Sciences from the Shoman Foundation (Jordon), and the Wellcome Trust (UK). Sherif is committed to value-led leadership, whereby building trust, equality, diversity, and inclusion are at the cornerstone of strategic developments to unlock the potential of people from all backgrounds.